National Research Corporation (NRC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $460.20M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Trent Green |
| IPO Date | 2013-05-23 | CAGR | 12.92% |
| Employees | 357 | Website | nrchealth.com |
| Div. Yield | 80.79% | Payout Ratio | 217% |
| Buy Back Yield | 67.17% | Total Yield | 147.96% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $518.16M | P/E | 24.9 | Forward P/E | 19.23 | PEG | — |
| P/S | 0.11 | P/B | 2.5 | P/CF | 0.56 | P/FCF | 0.77 |
| Sales | $140.00M | Sales 1Y | -0.23% | Sales 3Y | -5.71% | Sales 5Y | -0.1% |
| EPS | $0.82 | EPS 1Y | -67.02% | EPS 3Y | -78.43% | EPS 5Y | -81.97% |
| Sales QoQ | 1.69% | EPS QoQ | -207.14% | Sales QoQ Avg | 0.99% | EPS QoQ Avg | -1030.31% |
| Gross Margin | 41.51% | Operating Margin | 10.53% | Profit Margin | 4.18% | ROCE | 14.57% |
| ROA | 4% | ROE | 48% | Altman Z Score | 3.09 | Piotroski Score | 5 |
| Current Ratio | 0.65 | Quick Ratio | 0.65 | Cash Ratio | 0.1 | Op. CF Ratio | 0.04 |
| Debt/Equity | 13.75 | Debt/Assets | 0.66 | Lt Debt/Equity | 13.13 | Lt Debt/Cap. | 0.93 |
| Intrst Cov. | 5.33 | Inventory Turnover | — | Asset Turnover | 1.03 | Receivables Turnover | 15.01 |
| Enterprise Value | $518.16M | P/E Ratio | 24.9 |
| Forward P/E | 19.23 | PEG Ratio | — |
| P/S Ratio | 0.11 | P/B Ratio | 2.5 |
| P/CF Ratio | 0.56 | P/FCF Ratio | 0.77 |
| EPS | $0.82 | EPS Growth 1Y | -67.02% |
| EPS Growth 3Y | -78.43% | EPS Growth 5Y | -81.97% |
| Revenue Growth 1Y | -0.23% | Gross Margin | 41.51% |
| Operating Margin | 10.53% | Profit Margin | 4.18% |
| ROE | 48% | ROA | 4% |
| ROCE | 14.57% | Current Ratio | 0.65 |
| Quick Ratio | 0.65 | Cash Ratio | 0.1 |
| Debt/Equity | 13.75 | Interest Coverage | 5.33 |
| Altman Z Score | 3.09 | Piotroski Score | 5 |
National Research Corporation (NRC) valuation & financials
National Research Corporation (NRC) has a market capitalization of $460.20M and trades at a price-to-earnings ratio of 24.9. It operates in the Healthcare sector (Medical - Healthcare Information Services).
National Research Corporation's revenue grew -0.2% over the last year.
National Research Corporation's next earnings report is scheduled for October 26, 2026 (provider scheduled date); analysts estimate EPS of $0.21. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)